All articles by Aninda Chakraborty
Aninda Chakraborty
ArchiMed acquires neurodiagnostic devices provider Natus Medical
Natus shareholders received $33.50 in cash for each share of company common stock.
Anumana partners with Novartis for AI-driven heart disease detection
The companies will deploy multiple AI-powered software solutions to identify hidden cardiovascular conditions.
Labcorp introduces blood test to detect neurodegenerative disease
The test will help diagnose diseases, such as multiple sclerosis, Alzheimer’s and Parkinson’s, as well as brain injuries.
Medtronic enters partnership with CathWorks with $585m buyout option
Medtronic will immediately begin co-promotion of CathWorks’ FFRangio System in the US, Europe and Japan.
Eko secures FDA clearance for heart disease detection software
Use of the EMAS algorithm will enable healthcare professionals to identify valvular heart disease in patients.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
MMI introduces new simulator for microsurgeries
The new simulator is developed by medical simulation training company VirtaMed.
Nexus Medical Labs and Rhinostics obtain FDA EUA for SARS-CoV-2 Test
The molecular SARS-CoV-2 test relies on the RHINOstic Automated Nasal Swab from Rhinostics.
Medtronic’s revenue increases 5% to $31.69bn in FY22
The company’s fourth quarter worldwide revenue declined by 1% on a reported basis to $8.09bn.
NICE recommends Sleepio for insomnia patients instead of sleeping pills
The Sleepio app leverages an AI algorithm to offer customised digital cognitive behavioural therapy for insomnia (CBT-I).
Mainz and Dante Labs partner to commercialise colon cancer detection test
Mainz will leverage Dante’s various established commercial channels to introduce ColoAlert in Italy and the UAE.